MolGraph
CompoundsDocumentationComplianceAbout
MolGraph

Research chemical sourcing and molecular building block RFQ workflows.

MolGraph is operated by Tessorix Inc.

support@molgraph.com

Products are intended for laboratory research use only and are not for human or veterinary use.

Compounds

  • Compound catalog
  • CAS Search

Company

  • About
  • Contact

Documentation

  • Quality Documentation
  • SDS Disclaimer

Compliance

  • Compliance

Legal

  • Terms
  • Privacy

Copyright © 2026 MolGraph. All Rights Reserved.

Home/Compounds/CAS 114-07-8
Formula C37H67NO13MW 733.9Research-use catalog entryCOA/SDS by request

Erythromycin

CAS Number: 114-07-8

Sourcing & RFQ

Submit an RFQ to review pricing, availability, lead time, pack size, purity, COA, and supplier SDS for this catalog entry.

Available options

Available Options

Package
100 g
Purity
98%
Price
USD 160
Availability
Shipping review required
Delivery
Shipping review required

Price observed Jul 22, 2026

Package
25 g
Purity
98%
Price
USD 70
Availability
Shipping review required
Delivery
Shipping review required

Price observed Jul 22, 2026

Package
5 g
Purity
98%
Price
USD 50
Availability
Shipping review required
Delivery
Shipping review required

Price observed Jul 22, 2026

Shipping review is required before pricing or stock can be confirmed publicly. Shipping, duties, and documentation fees are confirmed before order acceptance.

Loading RDKit molecule structure...
InChIKey: ULGZDMOVFRHVEP-RWJQBGPGSA-NC37H67NO13 | MW 733.9

Chemical Absolute Identifiers

CAS Number

114-07-8

PubChem CID

12560

Molecular Formula

C37H67NO13

Molecular Weight

733.9 g/mol

Exact Mass

733.461241

InChIKey

ULGZDMOVFRHVEP-RWJQBGPGSA-N

IUPAC Name

(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione

SMILES String

CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O

Physical Properties

pKa

8.8–8.9

Show more physical data

Refractive Index

1.49

Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.

Catalog Facts

Structural features

Erythromycin (CAS 114-07-8) is listed in the Pharmaceutical Intermediates portfolio, with molecular formula C37H67NO13 and molecular weight 733. 90 g/mol.

Sourcing context

Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.

Research use context

Intended for research-stage medicinal chemistry and intermediate synthesis workflows; structure-derived tags include nitrogen-containing heterocycle.

Documentation needs

COA/SDS status, availability, lead time, pack size, and shipment documentation can be confirmed during quotation.

Applications & Classification

Pharmaceutical Intermediate ResearchResearch intermediateCustom synthesis building blockPharmaceutical intermediate researchResearch chemical sourcingCustom synthesis and catalog availability reviewCOA, SDS, pricing, and fulfillment workflow
Biological target reference

ChEMBL reports experimental activity evidence for: Voltage-gated inwardly rectifying potassium channel KCNH2 (Homo sapiens) — 8 assays; Motilin receptor (Homo sapiens) — 10 assays; Cytochrome P450 3A4 (Homo sapiens) — 8 assays; Motilin receptor (Oryctolagus cuniculus) — 5 assays; 5-hydroxytryptamine receptor 2A (Homo sapiens) — 3 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.

Voltage-gated inwardly rectifying potassium channel KCNH2

Homo sapiens · SINGLE PROTEIN · 8 qualifying assays · 5 documents · best pChEMBL 7.41

Experimental evidence source: ChEMBL

Motilin receptor

Homo sapiens · SINGLE PROTEIN · 10 qualifying assays · 7 documents · best pChEMBL 7.36

Experimental evidence source: ChEMBL

Cytochrome P450 3A4

Homo sapiens · SINGLE PROTEIN · 8 qualifying assays · 4 documents · best pChEMBL 6.72

Experimental evidence source: ChEMBL

Motilin receptor

Oryctolagus cuniculus · SINGLE PROTEIN · 5 qualifying assays · 3 documents · best pChEMBL 5.92

Experimental evidence source: ChEMBL

5-hydroxytryptamine receptor 2A

Homo sapiens · SINGLE PROTEIN · 3 qualifying assays · 1 documents · best pChEMBL 5.5

Experimental evidence source: ChEMBL

Safety & Handling

Safety and handling reference content is available through documentation requests.

For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.

Preliminary Safety Reference

For supplier-issued SDS or COA, submit a documentation request.

Safety Reference / SDS Request

Names & Synonyms / External Identifiers

Chemical Name

Erythromycin

Names & Synonyms

Erythromycin AAbomacetinEmgelErymaxIlotycin
Show all synonyms
EritromicinaErythromycineErythromycinumRobimycinErydermErythromycin baseErycetteErygelSansacE-MycinErythro-StatinErythra-DermAkne-MycinERYCE-Glades
External Identifiers
EC NUMBER: 204-040-1EC NUMBER: 616-217-4DSSTOX SUBSTANCE ID: DTXSID4022991CHEMBL ID: CHEMBL532CHEBI ID: CHEBI:42355UNII: 63937KV33DDRUGBANK ID: DB00199HMDB ID: HMDB0014344KEGG ID: C01912KEGG ID: D00140METABOLOMICS WORKBENCH ID: 21279NCI THESAURUS CODE: C476PHARMGKB ID: PA449493RXCUI: 4053WIKIDATA ID: Q213511
Experimental Spectrum References
13C NMR Spectra1H NMR SpectraATR-IR Spectra — Forensic Spectral ResearchFTIR SpectraRaman Spectra — Forensic Spectral Research
Literature & Patent References
DOI 10.1016/j.bmcl.2024.130084Discovery of 3-acyl-2-anilino-1,4-dihydroquinolin-4-one derivatives as potential inhibitors of methicillin-resistant Staphylococcus aureusDOI 10.1016/j.ejmech.2024.117101Discovery and optimization of tetrahydroacridine derivatives as a novel class of antibiotics against multidrug-resistant Gram-positive pathogens by targeting type I signal peptidase and disrupting bacterial membrane.DOI 10.1021/acs.jmedchem.4c01966Positive Charge-Concentrated Dimeric Lipopeptides with Enhanced Protease Resistance: A Potential Solution for Systemic Bacterial Infections.DOI 10.1021/acs.jmedchem.4c02562Structure-Guided Development of ClpP Agonists with Potent Therapeutic Activities against <i>Staphylococcus aureus</i> Infection.PMID 39626521Discovery and optimization of tetrahydroacridine derivatives as a novel class of antibiotics against multidrug-resistant Gram-positive pathogens by targeting type I signal peptidase and disrupting bacterial membrane.PMID 39742430Positive Charge-Concentrated Dimeric Lipopeptides with Enhanced Protease Resistance: A Potential Solution for Systemic Bacterial Infections.PMID 39760203Structure-Guided Development of ClpP Agonists with Potent Therapeutic Activities against <i>Staphylococcus aureus</i> Infection.DOI 10.1016/j.ejmech.2024.116181Synthesis and structure-activity relationships of novel 14-membered 2-fluoro ketolides with structural modification at the C11 position.

Documentation & Compliance Facts

Compliance Facts

Shipment review: Required

Documentation available by request

Certificate of Analysis (COA): By request

Supplier Safety Data Sheet (SDS): By request

Purity and pack size confirmation: By request

Availability and lead time review: Confirmed by RFQ

Shipment documentation review: By request

For supplier-issued documentation by request, use the RFQ actions on this page.Review preliminary safety reference

What happens after RFQ

  1. 1We review the CAS identity, quantity, and documentation request.
  2. 2We check sourcing options, supplier availability, COA/SDS, purity, pack size, and lead time.
  3. 3We review destination and shipment documentation needs when applicable.
  4. 4We follow up with a quotation or clarification request.

Text Reference Cues

Show non-linked catalog cues

Non-public related references

Erythromycin, cyclic 11,12-carbonateCAS 55224-05-0
9-Deoxo-9a-aza-9a-homoerythromycin ACAS 76801-85-9
RoxithromycinCAS 80214-83-1
DirithromycinCAS 62013-04-1
TulathromycinCAS 217500-96-4

Non-public references are shown as text only and do not imply equivalence, availability, or shared use.

Catalog navigation

Related Catalog Entries

Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.

CAS 55224-05-0Erythromycin, cyclic 11,12-carbonateCAS 76801-85-99-Deoxo-9a-aza-9a-homoerythromycin ACAS 80214-83-1RoxithromycinCAS 62013-04-1DirithromycinCAS 217500-96-4TulathromycinCAS 21829-25-4NifedipineCAS 181695-72-7ValdecoxibCAS 1393477-72-9SelinexorCAS 23593-75-1ClotrimazoleCAS 169590-42-5Celecoxib

RFQ questions for CAS 114-07-8

What are the key identifiers for Erythromycin (CAS 114-07-8)?

Erythromycin is identified by CAS 114-07-8, with molecular formula C37H67NO13, molecular weight 733.9, InChIKey ULGZDMOVFRHVEP-RWJQBGPGSA-N.

Does CAS 114-07-8 have reported biological target evidence?

ChEMBL contains qualifying experimental assay evidence associated with Voltage-gated inwardly rectifying potassium channel KCNH2, Motilin receptor, Cytochrome P450 3A4, Motilin receptor, 5-hydroxytryptamine receptor 2A. These records do not establish therapeutic efficacy or clinical use.

Can I request a COA for CAS 114-07-8?

Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.

Can I request supplier SDS for Erythromycin?

Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.

Is CAS 114-07-8 available for quotation?

Availability, pack size, lead time, and pricing are confirmed through RFQ.

Can MolGraph support bulk sourcing or custom synthesis review?

Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.